ES2394349B1 - Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar - Google Patents
Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar Download PDFInfo
- Publication number
- ES2394349B1 ES2394349B1 ES201231343A ES201231343A ES2394349B1 ES 2394349 B1 ES2394349 B1 ES 2394349B1 ES 201231343 A ES201231343 A ES 201231343A ES 201231343 A ES201231343 A ES 201231343A ES 2394349 B1 ES2394349 B1 ES 2394349B1
- Authority
- ES
- Spain
- Prior art keywords
- beta
- page
- pulmonary
- application
- issn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201231343A ES2394349B1 (es) | 2012-08-29 | 2012-08-29 | Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
| ES13785891T ES2863749T3 (es) | 2012-08-29 | 2013-08-28 | Agonistas de adrenoreceptores beta-3 para el tratamiento de hipertensión pulmonar debida a cardiopatía izquierda |
| DK13785891.6T DK2891490T3 (da) | 2012-08-29 | 2013-08-28 | Beta-3 adrenoceptor-agonister til behandlingen af pulmonal hypertension på grund af sygdom i venstre side af hjertet |
| PCT/ES2013/070611 WO2014033343A1 (es) | 2012-08-29 | 2013-08-28 | Agonistas de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
| EP13785891.6A EP2891490B1 (en) | 2012-08-29 | 2013-08-28 | Beta-3 adrenoceptor agonists for the treatment of pulmonary hypertension due to left heart disease |
| US14/424,861 US10532038B2 (en) | 2012-08-29 | 2013-08-28 | Beta-3 adrenoceptor agonists for the treatment of pulmonary hypertension |
| JP2015529082A JP6539206B2 (ja) | 2012-08-29 | 2013-08-28 | 肺高血圧症の治療のためのベータ−3アドレナリン受容体アゴニストの使用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201231343A ES2394349B1 (es) | 2012-08-29 | 2012-08-29 | Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ES2394349A1 ES2394349A1 (es) | 2013-01-30 |
| ES2394349A8 ES2394349A8 (es) | 2013-04-25 |
| ES2394349B1 true ES2394349B1 (es) | 2013-11-04 |
Family
ID=47520452
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201231343A Withdrawn - After Issue ES2394349B1 (es) | 2012-08-29 | 2012-08-29 | Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
| ES13785891T Active ES2863749T3 (es) | 2012-08-29 | 2013-08-28 | Agonistas de adrenoreceptores beta-3 para el tratamiento de hipertensión pulmonar debida a cardiopatía izquierda |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13785891T Active ES2863749T3 (es) | 2012-08-29 | 2013-08-28 | Agonistas de adrenoreceptores beta-3 para el tratamiento de hipertensión pulmonar debida a cardiopatía izquierda |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10532038B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2891490B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6539206B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2891490T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2394349B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014033343A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108290824B (zh) | 2015-10-23 | 2022-03-11 | B3Ar治疗股份有限公司 | 索拉贝隆两性离子及其应用 |
| WO2022198259A1 (en) * | 2021-03-25 | 2022-09-29 | The Heart Research Institute Ltd | Treatment methods for pulmonary arterial hypertension |
| EP4313019A4 (en) * | 2021-03-31 | 2025-02-12 | B3AR Therapeutics, Inc. | Compositions of micronized solabegron and methods of use |
| IT202300021417A1 (it) | 2023-10-13 | 2025-04-13 | Univ Pisa | Agonisti o attivatori del recettore adrenergico beta-3 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2965655D1 (en) | 1978-06-28 | 1983-07-21 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
| US4338333A (en) | 1979-06-16 | 1982-07-06 | Beecham Group Limited | Ethanamine derivatives their preparation and use in pharmaceutical compositions |
| ATE1899T1 (de) | 1979-06-16 | 1982-12-15 | Beecham Group Plc | Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen. |
| PT82120B (en) | 1985-03-01 | 1988-06-16 | Beecham Group Plc | Process for preparing veterinary formulations containing ethanolamine derivatives |
| GB8528633D0 (en) | 1985-11-21 | 1985-12-24 | Beecham Group Plc | Compounds |
| IT1204416B (it) | 1986-06-27 | 1989-03-01 | Midy Spa | Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini |
| GB8801306D0 (en) | 1988-01-21 | 1988-02-17 | Ici Plc | Chemical compounds |
| ATE144139T1 (de) | 1989-06-13 | 1996-11-15 | Sanofi Sa | Verwendung von phenylethanolaminen zur herstellung von medikamenten gegen augenleiden |
| GB8925032D0 (en) | 1989-11-06 | 1989-12-28 | Ici Plc | Chemical compounds |
| US5061727A (en) | 1990-05-04 | 1991-10-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
| ATE185564T1 (de) | 1992-08-31 | 1999-10-15 | Sankyo Co | Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung |
| US5578638A (en) | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| US5776983A (en) | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| NO303782B1 (no) | 1994-03-23 | 1998-08-31 | Sankyo Co | Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter |
| US5705515A (en) | 1994-04-26 | 1998-01-06 | Merck & Co., Inc. | Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity |
| US5561142A (en) | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| IL113410A (en) | 1994-04-26 | 1999-11-30 | Merck & Co Inc | Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them |
| JP3100165B2 (ja) | 1994-11-29 | 2000-10-16 | 大日本製薬株式会社 | インドール誘導体 |
| US5541204A (en) | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
| ES2158996T3 (es) | 1995-09-21 | 2001-09-16 | Lilly Co Eli | Agonistas beta3 adrenergicos selectivos. |
| ZA967892B (en) | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| CZ126598A3 (cs) | 1995-10-26 | 1998-09-16 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Fenylethanolaminové sloučeniny, způsob jejich výroby a farmaceutické prostředky s jejich obsahem |
| WO1997025311A1 (en) | 1996-01-10 | 1997-07-17 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel tricyclic compounds and drug compositions containing the same |
| US5770615A (en) | 1996-04-04 | 1998-06-23 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| EP0801060A1 (en) | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclic Beta-3 Adrenergenic Agonists |
| JP2000511903A (ja) | 1996-06-07 | 2000-09-12 | メルク エンド カンパニー インコーポレーテッド | 糖尿病および肥満の治療のための選択性β▲下3▼作動薬としてのオキサジアゾール・ベンゼンスルホンアミド |
| EP0827746B1 (en) | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
| IL131130A0 (en) | 1997-01-28 | 2001-01-28 | Merck & Co Inc | Thiazole benzenesulfonamides as beta3 agonists for the treatment of diabetes and obesity |
| AU735249B2 (en) | 1997-07-03 | 2001-07-05 | Asahi Kasei Kabushiki Kaisha | Novel tricyclic compounds having saturated rings and medicinal compositions containing the same |
| HUP0301329A2 (hu) | 2000-07-13 | 2003-08-28 | Eli Lilly And Co. | Béta3 Adrenergiás agonisták, valamint ezen vegyületeket tartalmazó gyógyászati készítmények és eljárás e vegyületek előállítására |
| US6537994B2 (en) | 2000-07-17 | 2003-03-25 | Wyeth | Heterocyclic β3 adrenergic receptor agonists |
| US20040242485A1 (en) | 2003-05-30 | 2004-12-02 | Takashi Kadowaki | Compositions and methods for the amelioration of leptin resistance |
| CN103068400A (zh) | 2010-06-25 | 2013-04-24 | 阿斯顿大学 | 具有脂类动员性质的糖蛋白及其治疗用途 |
| CN102764438A (zh) | 2012-01-30 | 2012-11-07 | 林曙光 | β3肾上腺素受体激动剂的新用途 |
-
2012
- 2012-08-29 ES ES201231343A patent/ES2394349B1/es not_active Withdrawn - After Issue
-
2013
- 2013-08-28 JP JP2015529082A patent/JP6539206B2/ja not_active Expired - Fee Related
- 2013-08-28 ES ES13785891T patent/ES2863749T3/es active Active
- 2013-08-28 EP EP13785891.6A patent/EP2891490B1/en active Active
- 2013-08-28 DK DK13785891.6T patent/DK2891490T3/da active
- 2013-08-28 WO PCT/ES2013/070611 patent/WO2014033343A1/es not_active Ceased
- 2013-08-28 US US14/424,861 patent/US10532038B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10532038B2 (en) | 2020-01-14 |
| EP2891490B1 (en) | 2020-12-09 |
| JP2015526497A (ja) | 2015-09-10 |
| EP2891490A1 (en) | 2015-07-08 |
| ES2863749T3 (es) | 2021-10-11 |
| ES2394349A1 (es) | 2013-01-30 |
| DK2891490T3 (da) | 2021-03-15 |
| WO2014033343A1 (es) | 2014-03-06 |
| WO2014033343A9 (es) | 2014-04-24 |
| US20150374655A1 (en) | 2015-12-31 |
| JP6539206B2 (ja) | 2019-07-03 |
| ES2394349A8 (es) | 2013-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2673081C1 (ru) | Сочетанные препараты неосакситоксина для пролонгированной местной анестезии | |
| ES2749096T3 (es) | Terapias de combinación para el tratamiento de la enfermedad de Alzheimery transtornos relacionados | |
| AU2018250214B2 (en) | Methods and compositions for treating aging-associated impairments using CCR3-inhibitors | |
| US20190134036A1 (en) | Topical formulations of pde-4 inhibitors and their methods of use | |
| CN109715151A (zh) | 用于治疗癫痫性紊乱的方法和组合物 | |
| Van der Schueren et al. | Calcitonin gene-related peptide8-37 antagonizes capsaicin-induced vasodilation in the skin: evaluation of a human in vivo pharmacodynamic model | |
| PT1112075E (pt) | Composições para o tratamento da disfunção eréctil masculina | |
| CN112166111A (zh) | 治疗纤维化疾病的方法 | |
| JP2017132802A (ja) | ヒストンアセチルトランスフェラーゼ活性剤の使用 | |
| ES2394349A1 (es) | Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar | |
| JP2014521694A (ja) | 安定な注射用抗炎症性溶液 | |
| TW200303214A (en) | Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 | |
| ES2858551T3 (es) | Antagonistas del receptor de tromboxano | |
| WO2024006841A2 (en) | Compositions for weight loss and cancer treatment | |
| KR20070036740A (ko) | 통증 완화 방법 | |
| ES2278930T3 (es) | Uso de un derivado de la piridazinona en el tratamiento de una insuficiencia cardiaca congestiva. | |
| US9629827B2 (en) | Methods of treating vasodilatory shock | |
| EP3607948A1 (en) | Tissue transglutaminase modulators for medicinal use | |
| US20110034504A1 (en) | Agent for preventing and/or treating vascular diseases | |
| ZA200507497B (en) | Therapeutic and/or preventive agent for chronic skin disease | |
| SK282353B6 (sk) | Farmaceutický prostriedok na intravenózne podanie | |
| Moriyama et al. | Effects of a novel benzodiazepine derivative, JM-1232 (-), on human gastroepiploic artery in vitro | |
| ES3062815T3 (en) | Compositions for treating aging-associated impairments using ccr3-inhibitors | |
| Ferreira | Cardiovascular activity of a new phenylpiperazine derivative of arylurethane | |
| KR20190017801A (ko) | 티몰롤을 포함하는 조성물 및 국소 투여에 의한 주사의 치료에 있어서의 이들의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2394349 Country of ref document: ES Kind code of ref document: B1 Effective date: 20131104 |
|
| FA2A | Application withdrawn |
Effective date: 20140318 |